Expression and Function of Macrophage Migration Inhibitory Factor (MIF) in Melioidosis

被引:16
作者
Wiersinga, W. Joost [1 ,2 ]
Calandra, Thierry [3 ,4 ]
Kager, Liesbeth M. [1 ,2 ]
van der Windt, Gerritje J. W. [1 ,2 ]
Roger, Thierry [3 ,4 ]
le Roy, Didier [3 ,4 ]
Florquin, Sandrine [5 ]
Peacock, Sharon J. [6 ,7 ]
Sweep, Fred C. G. J. [8 ]
van der Poll, Tom [1 ,2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, CINIMA, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands
[3] CHU Vaudois, Dept Med, Infect Dis Serv, Lausanne, Switzerland
[4] Univ Lausanne, Lausanne, Switzerland
[5] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[6] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand
[7] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England
[8] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
基金
瑞士国家科学基金会; 英国惠康基金;
关键词
INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTOR-4; BURKHOLDERIA-PSEUDOMALLEI; SEVERE SEPSIS; PULMONARY TUBERCULOSIS; SEPTIC SHOCK; ACTIVE-SITE; MICE; SERUM; ENDOTOXEMIA;
D O I
10.1371/journal.pntd.0000605
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Macrophage migration inhibitory factor (MIF) has emerged as a pivotal mediator of innate immunity and has been shown to be an important effector molecule in severe sepsis. Melioidosis, caused by Burkholderia pseudomallei, is an important cause of community-acquired sepsis in Southeast-Asia. We aimed to characterize the expression and function of MIF in melioidosis. Methodology and Principal Findings: MIF expression was determined in leukocytes and plasma from 34 melioidosis patients and 32 controls, and in mice infected with B. pseudomallei. MIF function was investigated in experimental murine melioidosis using anti-MIF antibodies and recombinant MIF. Patients demonstrated markedly increased MIF mRNA leukocyte and MIF plasma concentrations. Elevated MIF concentrations were associated with mortality. Mice inoculated intranasally with B. pseudomallei displayed a robust increase in pulmonary and systemic MIF expression. Anti-MIF treated mice showed lower bacterial loads in their lungs upon infection with a low inoculum. Conversely, mice treated with recombinant MIF displayed a modestly impaired clearance of B. pseudomallei. MIF exerted no direct effects on bacterial outgrowth or phagocytosis of B. pseudomallei. Conclusions: MIF concentrations are markedly elevated during clinical melioidosis and correlate with patients' outcomes. In experimental melioidosis MIF impaired antibacterial defense.
引用
收藏
页数:8
相关论文
共 51 条
[21]   Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis [J].
Emonts, Marieke ;
Sweep, Fred C. G. J. ;
Grebenchtchikov, Nicolai ;
Geurts-Moespot, Anneke ;
Knaup, Marlies ;
Chanson, Anne Laure ;
Erard, Veronique ;
Renner, Pascal ;
Hermans, Peter W. M. ;
Hazelzet, Jan A. ;
Calandra, Thierry .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (10) :1321-1328
[22]   An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood [J].
Grebenchtchikov, N ;
Sweep, CGJ ;
Geurts-Moespot, A ;
Piffanelli, A ;
Foekens, JA ;
Benraad, TJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 268 (02) :219-231
[23]   Biodefense-driven murine model of pneumonic melioidosis [J].
Jeddeloh, JA ;
Fritz, DL ;
Waag, DM ;
Hartings, JM ;
Andrews, GP .
INFECTION AND IMMUNITY, 2003, 71 (01) :584-587
[24]   Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases [J].
Kibiki, Gibson S. ;
van der Ven, Andre J. A. M. ;
Geurts-Moespot, Anneke ;
Shao, John ;
Calandra, Thierry ;
Sweep, Fred C. G. J. ;
Dolmans, Wil M. V. .
CLINICAL IMMUNOLOGY, 2007, 123 (01) :60-65
[25]   Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis [J].
Lehmann, LE ;
Novender, U ;
Schroeder, S ;
Pietsch, T ;
von Spiegel, T ;
Putensen, C ;
Hoeft, A ;
Stüber, F .
INTENSIVE CARE MEDICINE, 2001, 27 (08) :1412-1415
[26]   2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference [J].
Levy, MM ;
Fink, MP ;
Marshall, JC ;
Abraham, E ;
Angus, D ;
Cook, D ;
Cohen, J ;
Opal, SM ;
Vincent, JL ;
Ramsay, G .
CRITICAL CARE MEDICINE, 2003, 31 (04) :1250-1256
[27]   Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation [J].
Makita, H ;
Nishimura, M ;
Miyamoto, K ;
Nakano, T ;
Tanino, Y ;
Hirokawa, J ;
Nishihira, J ;
Kawakami, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :573-579
[28]   Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia [J].
Matsuda, Naoyuki ;
Nishihira, Jun ;
Takahashi, Yoshika ;
Kemmotsu, Osamu ;
Hattori, Yuichi .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 35 (02) :198-205
[29]   A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia [J].
McDevitt, Michael A. ;
Xie, Jianlin ;
Shanmugasundaram, Ganapathy ;
Griffith, Jason ;
Liu, Aihua ;
McDonald, Courtney ;
Thuma, Philip ;
Gordeuk, Victor R. ;
Metz, Christine N. ;
Mitchell, Robert ;
Keefer, Jeffrey ;
David, John ;
Leng, Lin ;
Bucala, Richard .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) :1185-1196
[30]   Mechanisms of disease: Acute lower respiratory tract infection [J].
Mizgerd, Joseph P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :716-727